PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Chen, B.R.* ; Deshpande, A.* ; Barbosa, K.O.* ; Kleppe, M.* ; Lei, X.* ; Yeddula, N.* ; Sánchez Vela, P.* ; Campos, A.R.* ; Wechsler-Reya, R.J.* ; Bagchi, A.* ; Meshinchi, S.* ; Eaves, C.J.* ; Jeremias, I. ; Haferlach, T.* ; Frank, D.A.* ; Ronai, Z.A.* ; Chanda, S.* ; Armstrong, S.A.* ; Adams, P.* ; Levine, R.L.*

A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis In AF10-rearranged AML.

Blood 137, 3403-3415 (2021)
Verlagsversion Postprint DOI PMC
Open Access Green
Leukemias bearing fusions of the AF10/MLLT10 gene are associated with poor prognosis, and therapies targeting these fusion proteins are lacking. To understand mechanisms underlying AF10 fusion-mediated leukemogenesis, we generated inducible mouse models of AML driven by the most common AF10 fusion proteins, PICALM/CALM-AF10 and KMT2A/MLL-AF10, and performed comprehensive characterization of the disease using transcriptomic, epigenomic, proteomic, and functional genomic approaches. Our studies provide a detailed map of gene networks and protein interactors associated with key AF10 fusions involved in leukemia. Specifically, we report that AF10 fusions activate a cascade of JAK/STAT-mediated inflammatory signaling through direct recruitment of JAK1 kinase. Inhibition of the JAK/STAT signaling by genetic Jak1 deletion or through pharmacological JAK/STAT inhibition elicited potent anti-oncogenic effects in mouse and human models of AF10 fusion AML. Collectively, our study identifies JAK1 as a tractable therapeutic target in AF10-rearranged leukemias.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
22.113
0.000
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Acute Myeloid-leukemia; Jak Inhibitors; Calm-af10; Fusion; Translocation; Atovaquone; Subgroups; T(10/11); Calm; Mll
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0006-4971
e-ISSN 1528-0020
Zeitschrift Blood
Quellenangaben Band: 137, Heft: 24, Seiten: 3403-3415 Artikelnummer: , Supplement: ,
Verlag American Society of Hematology
Verlagsort 2021 L St Nw, Suite 900, Washington, Dc 20036 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
POF Topic(s) 30204 - Cell Programming and Repair
Forschungsfeld(er) Stem Cell and Neuroscience
PSP-Element(e) G-506600-001
Förderungen Leukemia & Lymphoma Society
Rally Foundation for Childhood Cancer Research
Luke Tatsu Johnson Foundation
Children's Cancer Research Fund
V Foundation for Cancer Research (TVF)
Lady Tata Foundation
Memorial Sloan Kettering Cancer Center (MSKCC) from the NIH National Cancer Institute
NIH National Cancer Institute grant
Specialized Center of Research (SCOR) grants from the Leukemia & Lymphoma Society
NIH National Cancer Institute
National Institutes of Health (NIH) National Cancer Institute
DOI 10.1182/blood.2020009023
WOS ID WOS:000667999600006
Scopus ID 85108583209
PubMed ID 33690798
Erfassungsdatum 2021-05-18
[➜Korrektur melden]